Legal Does Not Mean Harmless: How Substances Shape the Developing Brain

Alcohol is legal. Energy drinks are sold in supermarkets. Nicotine products are packaged as lifestyle items. Painkillers are available without prescription. Medications are prescribed by doctors. Cannabis is being reclassified in many countries. Psychedelics are now being studied in clinical research.

But none of these categories answers the most important question:

What does a substance do to a brain that is still developing?

This paper challenges the way modern society talks about drugs, medication, and everyday stimulants. Public debates often divide substances into simple categories: legal or illegal, medical or recreational, accepted or forbidden, dangerous or harmless. But the developing brain does not respond to legal labels. It responds to pharmacology, dose, timing, frequency, context, stress, sleep, vulnerability, and interaction with other substances.

A young brain is not just a smaller adult brain. During adolescence and young adulthood, key capacities are still maturing: attention, impulse control, emotional regulation, memory, sleep stability, risk evaluation, reward processing, self-control, and long-term decision-making. Substances that interfere with these systems may therefore have a different meaning in young people than in mature adults.

The paper introduces the concept of neurodevelopmental integrity. This means protecting the inner capacities that later make real autonomy possible: clarity, self-regulation, emotional balance, learning ability, body awareness, healthy sleep, stress tolerance, and the ability to make responsible decisions.

The central message is uncomfortable but necessary:

A substance does not become safe because it is legal.
It does not become harmless because it is advertised.
It does not become neutral because adults are used to it.
And it does not automatically become more dangerous simply because it is forbidden.

Alcohol can strongly affect learning, memory, impulse control, and risk behavior. Nicotine can create dependence during a period when reward systems are highly sensitive. Energy drinks are not just harmless soft drinks; they are stimulant products that can affect sleep, anxiety, cardiovascular activation, stress regulation, and patterns of self-stimulation. Cannabis must be evaluated according to age, potency, frequency, mental health vulnerability, and context. Prescription medication can be necessary and protective, but it can also become problematic when used casually, too quickly, too long, or without proper monitoring.

Even over-the-counter painkillers are not automatically harmless. Paracetamol, ibuprofen, and aspirin can be useful medical tools, but they require knowledge about dosage, liver risk, kidney risk, stomach risk, interactions, and the difference between appropriate pain treatment and the habitual suppression of every minor discomfort.

Psychedelics show especially clearly why simplistic categories fail. Substances such as psilocybin, LSD, DMT, and mescaline are being investigated for therapeutic potential in carefully screened adults. But adult research does not mean adolescent safety. Psychedelics act deeply on perception, emotion, meaning, identity, and psychological processing. For a young or vulnerable person, this can be destabilizing if maturity, preparation, setting, support, and integration are missing.

The paper does not argue for naïve legalization, and it does not defend blind prohibition. It argues for something more demanding: a mature substance culture.

Such a culture does not minimize alcohol just because it is familiar. It does not ignore energy drinks just because they are sold everywhere. It does not treat medication as risk-free just because it is prescribed. It does not demonize psychedelics simply because they alter consciousness. And it does not leave young people alone with advertising, peer pressure, academic stress, sleep deprivation, party environments, and half-knowledge.

Risk is not determined by the substance alone. It is shaped by age, dose, frequency, mental state, sleep, stress, social pressure, medication, alcohol, heat, dehydration, physical exhaustion, party settings, and polydrug use. Many dangerous situations do not arise from one substance in isolation, but from the wrong combination in the wrong context.

That is why modern substance education must go beyond slogans and fear-based warnings. Young people need real risk literacy. They need to understand why sleep protects the brain, why mixing substances can be dangerous, why peer pressure changes decision-making, why caffeine-based performance culture is not neutral, and why a developing brain can be especially sensitive to pharmacological disruption.

For mature adults, the balance changes. Informed autonomy should carry more weight. Adults should be able to compare risks, understand context, and make responsible decisions. But real freedom does not come from ignorance. Autonomy requires education, not denial.

This paper calls for a new way of thinking about substance risk: less moral panic, less cultural blindness, less false normalization — and more developmental knowledge, honest education, harm reduction, and responsibility.

The decisive question is no longer:

Is this substance legal or illegal?

The real question is:

What does it do, at this age, in this body, in this state, in this setting, and at this dose — to the brain, consciousness, and future autonomy?

You can find the full scientific article in the International Journal on Science and Technology:

Elias Rubenstein (2026): Neurodevelopmental Integrity and Substance Risk: A Developmental Public Health Model for Education, Risk Literacy, and Adult Autonomy
DOI: in process

Elias Rubenstein: Neurodevelopmental Integrity and Substance Risk: A Developmental Public Health Model for Education, Risk Literacy, and Adult Autonomy.pdf